Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06559722
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-08-14
Brief Title:
A Trial Investigating the Efficacy and Safety of Insulin DegludecLiraglutide Injection in Subjects With Type 2 Diabetes
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A 26-WeekRandomisedOpen-LabelMulticenterActive-ControlledParallel-DesignPhase III Clinical Trial to Compare the Efficacy and Safety of Insulin DegludecLiraglutide Injection With XULTOPHY Once Daily Via Subcutaneous Injection in Chinese Subjects With Type 2 Diabetes
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a randomised open-label multicenter active-controlled parallel-design phase III clinical trial The purpose of this study to compare the efficacy and safety of Insulin DegludecLiraglutide Injection with XULTOPHY once daily via subcutaneous injection in Chinese Subjects with Type 2 Diabetes
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None